Germany · Delayed Price · Currency is EUR S2Medical AB Statistics
Total Valuation
S2Medical AB has a market cap or net worth of EUR 822,943. The enterprise value is 705,609.
| Market Cap | 822,943 |
| Enterprise Value | 705,609 |
Important Dates
The last earnings date was Tuesday, November 18, 2025.
| Earnings Date | Nov 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 836.14M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +241.73% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.01% |
| Float | 836.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.59 |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 1.48 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.85 |
| EV / Sales | 0.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75
| Current Ratio | 0.75 |
| Quick Ratio | 0.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -74.64 |
Financial Efficiency
Return on equity (ROE) is -19.05% and return on invested capital (ROIC) is -14.30%.
| Return on Equity (ROE) | -19.05% |
| Return on Assets (ROA) | -9.52% |
| Return on Invested Capital (ROIC) | -14.30% |
| Return on Capital Employed (ROCE) | -17.59% |
| Revenue Per Employee | 197,930 |
| Profits Per Employee | -35,353 |
| Employee Count | 7 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.07 |
Taxes
| Income Tax | -66,978 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.50% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -62.50% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 49.08 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, S2Medical AB had revenue of EUR 1.39 million and -247,468 in losses. Loss per share was -0.00.
| Revenue | 1.39M |
| Gross Profit | 1.22M |
| Operating Income | -297,304 |
| Pretax Income | -314,447 |
| Net Income | -247,468 |
| EBITDA | -238,502 |
| EBIT | -297,304 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 115,332 in cash and n/a in debt, giving a net cash position of 115,332.
| Cash & Cash Equivalents | 115,332 |
| Total Debt | n/a |
| Net Cash | 115,332 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.69M |
| Book Value Per Share | 0.00 |
| Working Capital | -160,462 |
Cash Flow
| Operating Cash Flow | 555,870 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 88.11%, with operating and profit margins of -21.46% and -17.86%.
| Gross Margin | 88.11% |
| Operating Margin | -21.46% |
| Pretax Margin | -22.70% |
| Profit Margin | -17.86% |
| EBITDA Margin | -17.21% |
| EBIT Margin | -21.46% |
| FCF Margin | n/a |
Dividends & Yields
S2Medical AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -241.73% |
| Shareholder Yield | -241.73% |
| Earnings Yield | -30.07% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |